Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 119 | 2024 | 3250 | 8.210 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 38 | 2024 | 558 | 7.050 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 47 | 2019 | 822 | 5.730 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 21 | 2024 | 256 | 3.650 |
Why?
|
Interleukin-9 | 8 | 2018 | 62 | 1.710 |
Why?
|
Immunosuppressive Agents | 21 | 2024 | 4206 | 1.330 |
Why?
|
Immunologic Factors | 13 | 2024 | 1596 | 1.260 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 2 | 2021 | 158 | 1.160 |
Why?
|
Lymphocyte Activation | 30 | 2016 | 5505 | 1.100 |
Why?
|
Disease Progression | 29 | 2024 | 13671 | 1.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 9 | 2019 | 977 | 1.050 |
Why?
|
Th17 Cells | 6 | 2017 | 791 | 0.980 |
Why?
|
Microglia | 8 | 2021 | 1376 | 0.930 |
Why?
|
T-Lymphocytes | 36 | 2011 | 10266 | 0.870 |
Why?
|
Laryngeal Masks | 1 | 2024 | 118 | 0.830 |
Why?
|
Immunoconjugates | 9 | 2008 | 975 | 0.820 |
Why?
|
Cytokines | 29 | 2017 | 7453 | 0.820 |
Why?
|
Vitamin D Deficiency | 3 | 2017 | 1388 | 0.810 |
Why?
|
Interferon-gamma | 31 | 2018 | 3160 | 0.810 |
Why?
|
T-Lymphocyte Subsets | 13 | 2018 | 1815 | 0.800 |
Why?
|
Adenoidectomy | 1 | 2024 | 171 | 0.790 |
Why?
|
Neuromyelitis Optica | 2 | 2024 | 266 | 0.790 |
Why?
|
Cholecalciferol | 2 | 2017 | 557 | 0.780 |
Why?
|
Interleukin-17 | 8 | 2018 | 924 | 0.780 |
Why?
|
Retina | 3 | 2024 | 2662 | 0.780 |
Why?
|
Th1 Cells | 15 | 2005 | 1042 | 0.750 |
Why?
|
Demyelinating Diseases | 8 | 2023 | 358 | 0.740 |
Why?
|
Dendritic Cells | 8 | 2014 | 2747 | 0.730 |
Why?
|
Optic Neuritis | 2 | 2022 | 175 | 0.710 |
Why?
|
Tonsillectomy | 1 | 2024 | 281 | 0.700 |
Why?
|
Immune Tolerance | 24 | 2012 | 2323 | 0.690 |
Why?
|
Cell Differentiation | 19 | 2018 | 11669 | 0.680 |
Why?
|
Albuterol | 3 | 2010 | 211 | 0.680 |
Why?
|
Viral Matrix Proteins | 1 | 2021 | 193 | 0.680 |
Why?
|
Autoimmunity | 11 | 2017 | 1361 | 0.670 |
Why?
|
Neural Stem Cells | 3 | 2019 | 895 | 0.670 |
Why?
|
Monocytes | 11 | 2013 | 2605 | 0.660 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2019 | 43 | 0.640 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2017 | 4415 | 0.630 |
Why?
|
T-Lymphocytes, Regulatory | 8 | 2019 | 3114 | 0.620 |
Why?
|
Stem Cells | 10 | 2008 | 3537 | 0.620 |
Why?
|
Calcifediol | 2 | 2017 | 160 | 0.620 |
Why?
|
Antigens, Ly | 2 | 2011 | 297 | 0.610 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1662 | 0.610 |
Why?
|
Central Nervous System | 10 | 2016 | 1346 | 0.610 |
Why?
|
Th2 Cells | 14 | 2008 | 1078 | 0.580 |
Why?
|
Tomography, Optical Coherence | 4 | 2024 | 2957 | 0.580 |
Why?
|
Toluidines | 1 | 2017 | 21 | 0.580 |
Why?
|
Crotonates | 1 | 2017 | 21 | 0.580 |
Why?
|
Fatigue | 1 | 2024 | 1557 | 0.570 |
Why?
|
Water Pollution | 1 | 2016 | 31 | 0.550 |
Why?
|
Oligodendroglia | 2 | 2019 | 540 | 0.540 |
Why?
|
Antigen-Presenting Cells | 9 | 2009 | 960 | 0.540 |
Why?
|
Membrane Glycoproteins | 13 | 2007 | 3711 | 0.540 |
Why?
|
Lectins | 1 | 2019 | 490 | 0.540 |
Why?
|
Interleukin-4 | 8 | 2013 | 1156 | 0.540 |
Why?
|
Exosomes | 1 | 2021 | 422 | 0.530 |
Why?
|
Cognition Disorders | 4 | 2021 | 3980 | 0.530 |
Why?
|
Lebanon | 12 | 2024 | 245 | 0.530 |
Why?
|
Water Purification | 1 | 2016 | 61 | 0.530 |
Why?
|
Smad3 Protein | 2 | 2017 | 166 | 0.530 |
Why?
|
Antigens, Differentiation | 9 | 2003 | 921 | 0.510 |
Why?
|
Propylene Glycols | 2 | 2015 | 91 | 0.510 |
Why?
|
Magnetic Resonance Imaging | 43 | 2024 | 36743 | 0.510 |
Why?
|
Disability Evaluation | 12 | 2024 | 1835 | 0.500 |
Why?
|
Animals | 108 | 2021 | 169246 | 0.490 |
Why?
|
Flow Cytometry | 13 | 2021 | 5902 | 0.490 |
Why?
|
Mice | 63 | 2021 | 82029 | 0.490 |
Why?
|
Humans | 216 | 2024 | 768166 | 0.480 |
Why?
|
Disabled Persons | 3 | 2023 | 1210 | 0.480 |
Why?
|
Thymus Gland | 6 | 1999 | 1266 | 0.480 |
Why?
|
Gadolinium | 5 | 2023 | 964 | 0.480 |
Why?
|
Nerve Degeneration | 4 | 2007 | 749 | 0.480 |
Why?
|
Peptides | 13 | 2013 | 4354 | 0.480 |
Why?
|
Calcitriol | 1 | 2016 | 303 | 0.460 |
Why?
|
Vitamins | 3 | 2017 | 1638 | 0.460 |
Why?
|
Interferon-beta | 8 | 2016 | 349 | 0.460 |
Why?
|
Female | 144 | 2024 | 397192 | 0.460 |
Why?
|
Mice, Inbred C57BL | 33 | 2021 | 22379 | 0.460 |
Why?
|
Brain | 40 | 2023 | 27360 | 0.450 |
Why?
|
Herpes Zoster | 1 | 2016 | 252 | 0.440 |
Why?
|
Signal Transduction | 20 | 2019 | 23645 | 0.440 |
Why?
|
Sphingosine | 2 | 2015 | 308 | 0.440 |
Why?
|
Severity of Illness Index | 16 | 2024 | 15948 | 0.440 |
Why?
|
Adrenergic beta-Agonists | 3 | 2010 | 347 | 0.420 |
Why?
|
Adjuvants, Immunologic | 7 | 2010 | 998 | 0.420 |
Why?
|
Adult | 98 | 2024 | 223646 | 0.410 |
Why?
|
Myelin Proteins | 9 | 2012 | 212 | 0.410 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2013 | 146 | 0.410 |
Why?
|
Autoimmune Diseases | 12 | 2013 | 2257 | 0.410 |
Why?
|
Interleukin-12 | 7 | 2006 | 577 | 0.410 |
Why?
|
Nerve Regeneration | 5 | 2015 | 797 | 0.410 |
Why?
|
Antigens, CD | 13 | 2009 | 4035 | 0.400 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 628 | 0.400 |
Why?
|
Recurrence | 18 | 2024 | 8509 | 0.400 |
Why?
|
Neurons | 11 | 2008 | 9514 | 0.400 |
Why?
|
Spinal Cord | 8 | 2024 | 1811 | 0.400 |
Why?
|
Receptor, Notch2 | 1 | 2012 | 90 | 0.390 |
Why?
|
Capsid Proteins | 1 | 2015 | 468 | 0.380 |
Why?
|
Osteopontin | 1 | 2013 | 306 | 0.380 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2012 | 75 | 0.370 |
Why?
|
Antigens, Surface | 6 | 2010 | 1617 | 0.360 |
Why?
|
Vitamin D | 3 | 2020 | 3311 | 0.360 |
Why?
|
Forkhead Transcription Factors | 4 | 2016 | 1625 | 0.360 |
Why?
|
Lymphocytes | 5 | 2015 | 2614 | 0.360 |
Why?
|
Male | 117 | 2024 | 364719 | 0.360 |
Why?
|
Exercise Test | 1 | 2018 | 2186 | 0.350 |
Why?
|
Tretinoin | 1 | 2013 | 524 | 0.350 |
Why?
|
Immunoglobulin G | 6 | 2024 | 4568 | 0.350 |
Why?
|
Neuropsychological Tests | 7 | 2021 | 7140 | 0.350 |
Why?
|
Cladribine | 3 | 2024 | 34 | 0.350 |
Why?
|
Cell Migration Inhibition | 1 | 2009 | 97 | 0.330 |
Why?
|
Middle Aged | 77 | 2024 | 223492 | 0.330 |
Why?
|
Mice, Inbred BALB C | 12 | 2012 | 6231 | 0.330 |
Why?
|
Myelin-Associated Glycoprotein | 6 | 2009 | 110 | 0.330 |
Why?
|
Herpesvirus 4, Human | 1 | 2015 | 1082 | 0.320 |
Why?
|
Cells, Cultured | 24 | 2016 | 19015 | 0.320 |
Why?
|
Receptor, Notch1 | 1 | 2012 | 519 | 0.320 |
Why?
|
Spectrum Analysis, Raman | 1 | 2011 | 253 | 0.310 |
Why?
|
Middle East | 7 | 2019 | 233 | 0.310 |
Why?
|
Immunologic Surveillance | 1 | 2009 | 93 | 0.310 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2011 | 952 | 0.300 |
Why?
|
Refugees | 1 | 2016 | 615 | 0.300 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1656 | 0.290 |
Why?
|
Stem Cell Niche | 1 | 2011 | 347 | 0.290 |
Why?
|
Cognition | 5 | 2021 | 7073 | 0.290 |
Why?
|
Trans-Activators | 4 | 2008 | 2857 | 0.290 |
Why?
|
Retinal Ganglion Cells | 2 | 2024 | 811 | 0.280 |
Why?
|
Meninges | 1 | 2009 | 197 | 0.280 |
Why?
|
Apoptosis | 7 | 2010 | 9523 | 0.280 |
Why?
|
Membrane Proteins | 6 | 2012 | 7876 | 0.280 |
Why?
|
Scleroderma, Systemic | 1 | 2011 | 346 | 0.280 |
Why?
|
Macrophages | 3 | 2021 | 5799 | 0.280 |
Why?
|
Transforming Growth Factor beta | 9 | 2012 | 1996 | 0.280 |
Why?
|
Cerebral Cortex | 6 | 2010 | 5812 | 0.270 |
Why?
|
Calcium-Binding Proteins | 2 | 2011 | 1083 | 0.270 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2011 | 2892 | 0.260 |
Why?
|
Antigen Presentation | 6 | 2016 | 1251 | 0.260 |
Why?
|
Cell Movement | 11 | 2015 | 5210 | 0.250 |
Why?
|
Microscopy | 1 | 2011 | 909 | 0.250 |
Why?
|
Nervous System | 2 | 2006 | 544 | 0.250 |
Why?
|
CD40 Ligand | 8 | 2002 | 528 | 0.250 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 2 | 2024 | 133 | 0.250 |
Why?
|
Antibodies, Monoclonal | 6 | 2016 | 9263 | 0.250 |
Why?
|
Axons | 2 | 2011 | 1677 | 0.240 |
Why?
|
Models, Immunological | 1 | 2007 | 518 | 0.240 |
Why?
|
Oligoclonal Bands | 1 | 2024 | 17 | 0.240 |
Why?
|
Microscopy, Confocal | 5 | 2010 | 1972 | 0.240 |
Why?
|
Rats, Inbred Lew | 15 | 2001 | 1162 | 0.240 |
Why?
|
Immunologic Memory | 3 | 2015 | 1377 | 0.240 |
Why?
|
Autoantibodies | 5 | 2024 | 2121 | 0.230 |
Why?
|
Oncogene Proteins | 1 | 2008 | 717 | 0.230 |
Why?
|
Young Adult | 20 | 2020 | 60066 | 0.230 |
Why?
|
Adoptive Transfer | 7 | 2016 | 825 | 0.230 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 771 | 0.220 |
Why?
|
Stem Cell Transplantation | 3 | 2007 | 1596 | 0.220 |
Why?
|
Aquaporin 4 | 1 | 2024 | 161 | 0.220 |
Why?
|
Overweight | 1 | 2015 | 2448 | 0.220 |
Why?
|
Autoantigens | 9 | 2012 | 890 | 0.220 |
Why?
|
Ovalbumin | 6 | 2004 | 677 | 0.220 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2005 | 361 | 0.220 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2015 | 133 | 0.220 |
Why?
|
Registries | 6 | 2024 | 8375 | 0.210 |
Why?
|
Neuroglia | 4 | 2009 | 960 | 0.210 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2013 | 3814 | 0.210 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2709 | 0.200 |
Why?
|
Mice, Transgenic | 11 | 2011 | 9561 | 0.200 |
Why?
|
Corpus Callosum | 1 | 2007 | 753 | 0.200 |
Why?
|
Inflammation | 6 | 2009 | 10873 | 0.200 |
Why?
|
Neural Crest | 1 | 2004 | 278 | 0.200 |
Why?
|
Cyclophosphamide | 6 | 2004 | 2227 | 0.200 |
Why?
|
Quality of Life | 6 | 2024 | 13490 | 0.200 |
Why?
|
Interleukin-2 | 8 | 2014 | 1895 | 0.200 |
Why?
|
Spleen | 8 | 2010 | 2295 | 0.200 |
Why?
|
Cerebellar Nuclei | 2 | 2019 | 54 | 0.200 |
Why?
|
Research | 3 | 2019 | 1979 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2009 | 4648 | 0.200 |
Why?
|
Multipotent Stem Cells | 1 | 2003 | 201 | 0.200 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1752 | 0.190 |
Why?
|
Blood Proteins | 3 | 2023 | 1191 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4580 | 0.190 |
Why?
|
Meglumine | 2 | 2019 | 144 | 0.190 |
Why?
|
Drug Substitution | 1 | 2024 | 291 | 0.190 |
Why?
|
Inflammation Mediators | 4 | 2010 | 1892 | 0.190 |
Why?
|
Atrophy | 7 | 2012 | 1646 | 0.190 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 110 | 0.180 |
Why?
|
JC Virus | 2 | 2024 | 87 | 0.180 |
Why?
|
Malformations of Cortical Development | 1 | 2023 | 176 | 0.180 |
Why?
|
Cell Proliferation | 11 | 2019 | 10474 | 0.180 |
Why?
|
Antigens | 6 | 1999 | 1442 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2001 | 587 | 0.180 |
Why?
|
Immune System Diseases | 1 | 2003 | 253 | 0.180 |
Why?
|
Arabs | 2 | 2020 | 190 | 0.180 |
Why?
|
Smoking | 2 | 2015 | 9092 | 0.170 |
Why?
|
Administration, Oral | 16 | 2015 | 4030 | 0.170 |
Why?
|
Cohort Studies | 13 | 2024 | 41754 | 0.170 |
Why?
|
Neuromuscular Diseases | 1 | 2003 | 260 | 0.170 |
Why?
|
Transplantation Tolerance | 2 | 2002 | 633 | 0.170 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26379 | 0.170 |
Why?
|
Receptors, CXCR4 | 1 | 2004 | 729 | 0.170 |
Why?
|
Cell Separation | 4 | 2011 | 1728 | 0.170 |
Why?
|
Bromodeoxyuridine | 2 | 2011 | 310 | 0.170 |
Why?
|
STAT3 Transcription Factor | 2 | 2017 | 874 | 0.170 |
Why?
|
Interleukin-10 | 4 | 2016 | 1183 | 0.160 |
Why?
|
Maze Learning | 1 | 2021 | 482 | 0.160 |
Why?
|
Hexosaminidases | 1 | 2019 | 45 | 0.160 |
Why?
|
Disease Models, Animal | 11 | 2021 | 18349 | 0.160 |
Why?
|
Prostatic Hyperplasia | 2 | 1994 | 516 | 0.160 |
Why?
|
Up-Regulation | 6 | 2008 | 4146 | 0.160 |
Why?
|
Mice, Knockout | 11 | 2016 | 14488 | 0.160 |
Why?
|
Nonlinear Dynamics | 1 | 2021 | 493 | 0.160 |
Why?
|
Myelin Proteolipid Protein | 5 | 2011 | 107 | 0.150 |
Why?
|
STAT6 Transcription Factor | 4 | 2008 | 196 | 0.150 |
Why?
|
Polysaccharides | 3 | 2015 | 1024 | 0.150 |
Why?
|
Interferon Regulatory Factors | 2 | 2018 | 271 | 0.150 |
Why?
|
Organometallic Compounds | 2 | 2019 | 648 | 0.150 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2016 | 1134 | 0.150 |
Why?
|
Pregnancy, Multiple | 1 | 1999 | 216 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 7 | 2001 | 1441 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2016 | 2568 | 0.150 |
Why?
|
Verbal Learning | 1 | 2020 | 465 | 0.150 |
Why?
|
Mice, Inbred Strains | 5 | 2007 | 1765 | 0.150 |
Why?
|
Urologic Diseases | 1 | 2000 | 246 | 0.150 |
Why?
|
Longitudinal Studies | 15 | 2024 | 14783 | 0.150 |
Why?
|
Gene Expression | 5 | 2016 | 7598 | 0.150 |
Why?
|
Contrast Media | 4 | 2019 | 5330 | 0.150 |
Why?
|
Teratoma | 1 | 2001 | 405 | 0.150 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2012 | 827 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 3 | 2012 | 1854 | 0.150 |
Why?
|
Hospitals, University | 1 | 2019 | 570 | 0.140 |
Why?
|
Globus Pallidus | 1 | 2018 | 248 | 0.140 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2001 | 335 | 0.140 |
Why?
|
Clonal Anergy | 1 | 1998 | 169 | 0.140 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2011 | 687 | 0.140 |
Why?
|
Hydroxybutyrates | 1 | 2017 | 76 | 0.140 |
Why?
|
Interferons | 1 | 2021 | 720 | 0.140 |
Why?
|
Models, Psychological | 1 | 2021 | 825 | 0.140 |
Why?
|
Hypersensitivity, Delayed | 6 | 1997 | 491 | 0.140 |
Why?
|
Consensus | 4 | 2024 | 3212 | 0.140 |
Why?
|
Sex Factors | 6 | 2022 | 10632 | 0.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7454 | 0.140 |
Why?
|
Risk Assessment | 1 | 2018 | 24315 | 0.140 |
Why?
|
Molecular Sequence Data | 9 | 2009 | 17622 | 0.140 |
Why?
|
Amino Acid Sequence | 9 | 2009 | 13421 | 0.140 |
Why?
|
Neurodegenerative Diseases | 2 | 2008 | 1095 | 0.140 |
Why?
|
Anesthesia, Obstetrical | 1 | 1999 | 235 | 0.140 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 1998 | 180 | 0.140 |
Why?
|
Retrospective Studies | 21 | 2024 | 81762 | 0.130 |
Why?
|
Neural Pathways | 1 | 2007 | 3117 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2015 | 10760 | 0.130 |
Why?
|
Physicians, Women | 1 | 2022 | 517 | 0.130 |
Why?
|
Treatment Outcome | 10 | 2024 | 65371 | 0.130 |
Why?
|
Peptide Fragments | 9 | 2011 | 5151 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2010 | 638 | 0.130 |
Why?
|
Breast Feeding | 1 | 2024 | 1363 | 0.130 |
Why?
|
Intubation, Intratracheal | 1 | 2024 | 1359 | 0.130 |
Why?
|
Models, Neurological | 3 | 2021 | 1776 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2433 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2006 | 82 | 0.120 |
Why?
|
Immunity, Cellular | 5 | 2005 | 1561 | 0.120 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 381 | 0.120 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2016 | 246 | 0.120 |
Why?
|
Receptors, OX40 | 2 | 2008 | 46 | 0.120 |
Why?
|
Rats | 21 | 2006 | 23760 | 0.120 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 1989 | 410 | 0.120 |
Why?
|
Histocompatibility Antigens | 5 | 2001 | 479 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2003 | 1801 | 0.120 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2018 | 858 | 0.120 |
Why?
|
Time Factors | 14 | 2011 | 40218 | 0.120 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 1996 | 137 | 0.120 |
Why?
|
Sleep Disorders, Intrinsic | 1 | 2014 | 16 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2001 | 806 | 0.120 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 432 | 0.120 |
Why?
|
Injections, Intralymphatic | 3 | 1999 | 15 | 0.120 |
Why?
|
Voluntary Health Agencies | 1 | 1994 | 38 | 0.110 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 1994 | 171 | 0.110 |
Why?
|
International Cooperation | 3 | 2010 | 1436 | 0.110 |
Why?
|
Case-Control Studies | 6 | 2023 | 22291 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 945 | 0.110 |
Why?
|
Chronobiology Disorders | 1 | 2014 | 73 | 0.110 |
Why?
|
DNA-Binding Proteins | 4 | 2014 | 9615 | 0.110 |
Why?
|
Program Evaluation | 2 | 2019 | 2507 | 0.110 |
Why?
|
Polyomavirus Infections | 1 | 2015 | 192 | 0.110 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 361 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2015 | 526 | 0.110 |
Why?
|
Retinal Dehydrogenase | 1 | 2013 | 78 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2008 | 812 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1406 | 0.110 |
Why?
|
Graft Rejection | 6 | 2009 | 4492 | 0.110 |
Why?
|
Cell Division | 6 | 2004 | 4473 | 0.110 |
Why?
|
Double-Blind Method | 6 | 2019 | 12465 | 0.110 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2010 | 287 | 0.110 |
Why?
|
Major Histocompatibility Complex | 3 | 2002 | 877 | 0.110 |
Why?
|
Statistics as Topic | 3 | 2016 | 2357 | 0.100 |
Why?
|
Prostaglandins E | 1 | 1992 | 166 | 0.100 |
Why?
|
Encephalitis | 1 | 2017 | 441 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2001 | 1061 | 0.100 |
Why?
|
Methylprednisolone | 3 | 1999 | 386 | 0.100 |
Why?
|
Tumor Virus Infections | 1 | 2015 | 437 | 0.100 |
Why?
|
STAT5 Transcription Factor | 2 | 2014 | 268 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 257 | 0.100 |
Why?
|
Immunomodulation | 1 | 2016 | 549 | 0.100 |
Why?
|
Receptors, Interleukin-9 | 1 | 2012 | 4 | 0.100 |
Why?
|
Prostatic Neoplasms | 7 | 1996 | 11101 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2913 | 0.100 |
Why?
|
Astrocytes | 3 | 2012 | 1350 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2012 | 9118 | 0.100 |
Why?
|
HLA-B Antigens | 2 | 2010 | 330 | 0.100 |
Why?
|
HLA-DR Antigens | 2 | 2010 | 609 | 0.100 |
Why?
|
Amino Sugars | 1 | 2011 | 39 | 0.100 |
Why?
|
Nitriles | 1 | 2017 | 980 | 0.100 |
Why?
|
Age Factors | 8 | 2017 | 18412 | 0.100 |
Why?
|
Prospective Studies | 15 | 2022 | 54926 | 0.100 |
Why?
|
Blotting, Western | 2 | 2011 | 5027 | 0.100 |
Why?
|
Down-Regulation | 3 | 2007 | 2937 | 0.100 |
Why?
|
HEK293 Cells | 2 | 2019 | 4283 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1494 | 0.100 |
Why?
|
RNA | 2 | 2012 | 2720 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2016 | 733 | 0.100 |
Why?
|
Galectin 1 | 1 | 2012 | 128 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2016 | 7608 | 0.090 |
Why?
|
Lipopolysaccharides | 3 | 2001 | 2219 | 0.090 |
Why?
|
Immune System | 2 | 2008 | 799 | 0.090 |
Why?
|
Amyloid beta-Peptides | 2 | 2006 | 3914 | 0.090 |
Why?
|
Gene Expression Regulation | 7 | 2018 | 11928 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2001 | 2846 | 0.090 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
Drug Therapy, Combination | 7 | 2010 | 6316 | 0.090 |
Why?
|
Immunophenotyping | 5 | 2008 | 1864 | 0.090 |
Why?
|
Isoantigens | 3 | 2001 | 562 | 0.090 |
Why?
|
Immunization | 5 | 2016 | 1219 | 0.090 |
Why?
|
Thymectomy | 3 | 1997 | 200 | 0.090 |
Why?
|
Psychometrics | 1 | 2020 | 3063 | 0.090 |
Why?
|
Alzheimer Disease | 4 | 2019 | 8759 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 6 | 2016 | 18065 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2359 | 0.090 |
Why?
|
Immunoblotting | 1 | 2013 | 1647 | 0.090 |
Why?
|
Minocycline | 1 | 2011 | 170 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5100 | 0.080 |
Why?
|
Age of Onset | 5 | 2023 | 3347 | 0.080 |
Why?
|
Muromonab-CD3 | 1 | 2009 | 104 | 0.080 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 4860 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2019 | 1481 | 0.080 |
Why?
|
Prostatism | 1 | 2009 | 16 | 0.080 |
Why?
|
Immunotherapy | 5 | 2012 | 4755 | 0.080 |
Why?
|
Prognosis | 11 | 2024 | 30010 | 0.080 |
Why?
|
Subarachnoid Space | 1 | 2009 | 79 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2009 | 660 | 0.080 |
Why?
|
Brain Chemistry | 1 | 1992 | 958 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2016 | 2741 | 0.080 |
Why?
|
Bruxism | 1 | 2008 | 13 | 0.080 |
Why?
|
Ligands | 3 | 2007 | 3284 | 0.080 |
Why?
|
Carotid Artery Thrombosis | 1 | 1988 | 49 | 0.080 |
Why?
|
Phenotype | 5 | 2017 | 16726 | 0.080 |
Why?
|
Immunohistochemistry | 6 | 2010 | 11095 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 1992 | 646 | 0.080 |
Why?
|
Masticatory Muscles | 1 | 2008 | 31 | 0.080 |
Why?
|
Kuwait | 2 | 2019 | 94 | 0.080 |
Why?
|
HLA Antigens | 2 | 2010 | 1334 | 0.080 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39348 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2017 | 3620 | 0.080 |
Why?
|
Gene Expression Profiling | 4 | 2012 | 9538 | 0.080 |
Why?
|
Interleukin-13 | 1 | 2010 | 390 | 0.070 |
Why?
|
Pelvic Organ Prolapse | 1 | 2010 | 116 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1750 | 0.070 |
Why?
|
Receptors, Notch | 2 | 2015 | 751 | 0.070 |
Why?
|
Chronic Disease | 5 | 2010 | 9384 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2011 | 517 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20227 | 0.070 |
Why?
|
Femoral Artery | 2 | 2008 | 829 | 0.070 |
Why?
|
src Homology Domains | 1 | 2008 | 361 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2016 | 6229 | 0.070 |
Why?
|
Africa, Northern | 2 | 2019 | 86 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 1998 | 1481 | 0.070 |
Why?
|
Blood-Brain Barrier | 2 | 2012 | 1034 | 0.070 |
Why?
|
Endarterectomy | 1 | 1988 | 196 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2009 | 202 | 0.070 |
Why?
|
Embryo, Mammalian | 3 | 2008 | 1676 | 0.070 |
Why?
|
Nitric Oxide | 2 | 2011 | 2146 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8230 | 0.070 |
Why?
|
Femoral Vein | 1 | 2008 | 155 | 0.070 |
Why?
|
Receptors, CXCR3 | 1 | 2008 | 240 | 0.070 |
Why?
|
Epilepsy | 1 | 2023 | 3327 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2008 | 897 | 0.070 |
Why?
|
Chemokine CXCL10 | 2 | 2013 | 311 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2885 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10399 | 0.070 |
Why?
|
Fecal Incontinence | 1 | 2010 | 246 | 0.070 |
Why?
|
Myelin Sheath | 4 | 2009 | 652 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1085 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1832 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12077 | 0.070 |
Why?
|
Medulla Oblongata | 1 | 2008 | 248 | 0.070 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2008 | 225 | 0.070 |
Why?
|
Cell Line | 7 | 2004 | 15597 | 0.070 |
Why?
|
B-Lymphocytes | 3 | 2009 | 4793 | 0.070 |
Why?
|
Disease Susceptibility | 2 | 2006 | 1793 | 0.070 |
Why?
|
Societies, Medical | 2 | 2000 | 3968 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2011 | 4063 | 0.070 |
Why?
|
Parkinson Disease | 2 | 2019 | 2893 | 0.070 |
Why?
|
Algorithms | 3 | 2023 | 14164 | 0.060 |
Why?
|
Glycoproteins | 3 | 2009 | 2202 | 0.060 |
Why?
|
Immunity, Innate | 3 | 2011 | 3080 | 0.060 |
Why?
|
Kinetics | 3 | 1998 | 6329 | 0.060 |
Why?
|
Fetal Resorption | 1 | 2005 | 15 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2008 | 753 | 0.060 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2005 | 11 | 0.060 |
Why?
|
Chemokine CCL2 | 2 | 2012 | 605 | 0.060 |
Why?
|
Leptin | 1 | 2013 | 1599 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3007 | 0.060 |
Why?
|
Urinary Incontinence | 1 | 2010 | 490 | 0.060 |
Why?
|
Gadolinium DTPA | 2 | 2019 | 823 | 0.060 |
Why?
|
Protein Binding | 5 | 2016 | 9343 | 0.060 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2005 | 188 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2973 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 3740 | 0.060 |
Why?
|
Urology | 1 | 2010 | 384 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5717 | 0.060 |
Why?
|
Pilot Projects | 4 | 2020 | 8741 | 0.060 |
Why?
|
Receptors, Interleukin-2 | 3 | 2005 | 564 | 0.060 |
Why?
|
Hematopoietic System | 1 | 2005 | 110 | 0.060 |
Why?
|
Cell Communication | 1 | 2012 | 1660 | 0.060 |
Why?
|
Aged | 17 | 2018 | 171504 | 0.060 |
Why?
|
STAT4 Transcription Factor | 2 | 2001 | 94 | 0.060 |
Why?
|
Janus Kinase 1 | 1 | 2005 | 108 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 874 | 0.060 |
Why?
|
Adolescent | 16 | 2018 | 89169 | 0.060 |
Why?
|
Antibody Formation | 3 | 2003 | 1393 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1474 | 0.060 |
Why?
|
Lingual Frenum | 1 | 2024 | 9 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2005 | 210 | 0.060 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2008 | 291 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3800 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2013 | 4352 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2007 | 557 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4598 | 0.060 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1375 | 0.060 |
Why?
|
Hepatitis C Antibodies | 2 | 2001 | 151 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4543 | 0.060 |
Why?
|
Carotid Arteries | 1 | 1988 | 942 | 0.060 |
Why?
|
Sex Characteristics | 2 | 2013 | 2650 | 0.060 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2016 | 151 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3216 | 0.050 |
Why?
|
Leukocytosis | 1 | 2024 | 251 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2001 | 6395 | 0.050 |
Why?
|
ADP-Ribosylation Factors | 1 | 2003 | 131 | 0.050 |
Why?
|
Brain Stem | 1 | 2008 | 859 | 0.050 |
Why?
|
Maternal-Fetal Exchange | 1 | 2005 | 454 | 0.050 |
Why?
|
Gastroenterology | 1 | 2010 | 593 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2005 | 2167 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2065 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2005 | 794 | 0.050 |
Why?
|
Students, Medical | 1 | 2016 | 1964 | 0.050 |
Why?
|
Homeodomain Proteins | 3 | 2012 | 2429 | 0.050 |
Why?
|
Galectins | 1 | 2005 | 295 | 0.050 |
Why?
|
Databases, Factual | 2 | 2017 | 8080 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2474 | 0.050 |
Why?
|
Biomedical Research | 2 | 2016 | 3463 | 0.050 |
Why?
|
Chemokine CCL7 | 1 | 2002 | 30 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2004 | 590 | 0.050 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2002 | 48 | 0.050 |
Why?
|
Brain Injuries | 1 | 2014 | 2057 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1361 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Cost of Illness | 2 | 2023 | 1951 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2005 | 483 | 0.050 |
Why?
|
NAD | 1 | 2006 | 618 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2003 | 252 | 0.050 |
Why?
|
Cerebral Ventricles | 1 | 2004 | 550 | 0.050 |
Why?
|
Interleukins | 1 | 2007 | 796 | 0.050 |
Why?
|
Chemokine CXCL9 | 1 | 2002 | 135 | 0.050 |
Why?
|
Reference Values | 4 | 2020 | 4938 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2005 | 652 | 0.050 |
Why?
|
Seroepidemiologic Studies | 3 | 2015 | 404 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2024 | 15832 | 0.050 |
Why?
|
Phagocytosis | 1 | 2007 | 1530 | 0.050 |
Why?
|
Bucladesine | 1 | 2001 | 118 | 0.050 |
Why?
|
Abdominal Injuries | 2 | 1996 | 362 | 0.050 |
Why?
|
Droperidol | 1 | 2001 | 21 | 0.050 |
Why?
|
Seasons | 2 | 1998 | 1524 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2012 | 3228 | 0.050 |
Why?
|
Metoclopramide | 1 | 2001 | 51 | 0.050 |
Why?
|
Image Enhancement | 1 | 2012 | 2880 | 0.050 |
Why?
|
Ambulatory Care | 1 | 1992 | 2783 | 0.050 |
Why?
|
Wounds, Penetrating | 2 | 1996 | 316 | 0.050 |
Why?
|
Logistic Models | 3 | 2010 | 13290 | 0.050 |
Why?
|
Models, Statistical | 3 | 2022 | 5107 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2003 | 1151 | 0.050 |
Why?
|
OX40 Ligand | 1 | 2001 | 57 | 0.050 |
Why?
|
Prevalence | 4 | 2024 | 15869 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2001 | 109 | 0.050 |
Why?
|
Rats, Inbred WF | 5 | 2001 | 140 | 0.050 |
Why?
|
Transplantation Immunology | 2 | 2001 | 537 | 0.050 |
Why?
|
Topography, Medical | 2 | 2001 | 37 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2909 | 0.050 |
Why?
|
Skin Physiological Phenomena | 1 | 2001 | 193 | 0.040 |
Why?
|
Hepatitis C | 2 | 2001 | 1595 | 0.040 |
Why?
|
Clone Cells | 5 | 2008 | 1670 | 0.040 |
Why?
|
Occupational Diseases | 2 | 2001 | 1457 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2819 | 0.040 |
Why?
|
Chemokines, CXC | 1 | 2002 | 420 | 0.040 |
Why?
|
Lymph Nodes | 6 | 2016 | 3474 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2008 | 928 | 0.040 |
Why?
|
Ondansetron | 1 | 2001 | 95 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2002 | 251 | 0.040 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2000 | 93 | 0.040 |
Why?
|
Child | 10 | 2024 | 80917 | 0.040 |
Why?
|
Iron | 1 | 2009 | 1813 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3603 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3781 | 0.040 |
Why?
|
Complementary Therapies | 1 | 2024 | 487 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2003 | 572 | 0.040 |
Why?
|
Glioma | 2 | 2012 | 3503 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2006 | 958 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1265 | 0.040 |
Why?
|
Anesthesia, Inhalation | 1 | 2000 | 220 | 0.040 |
Why?
|
Career Mobility | 1 | 2022 | 262 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 1996 | 11244 | 0.040 |
Why?
|
Cycloheximide | 1 | 1999 | 341 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6874 | 0.040 |
Why?
|
Antiemetics | 1 | 2001 | 188 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5953 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.040 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1996 | 94 | 0.040 |
Why?
|
Health Care Costs | 2 | 2023 | 3239 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2002 | 704 | 0.040 |
Why?
|
Epitopes | 2 | 1997 | 2528 | 0.040 |
Why?
|
Drug Resistance | 4 | 2010 | 1599 | 0.040 |
Why?
|
Kidney Transplantation | 3 | 2004 | 4262 | 0.040 |
Why?
|
Desensitization, Immunologic | 2 | 1995 | 558 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6291 | 0.040 |
Why?
|
Blood Donors | 1 | 2001 | 343 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2001 | 285 | 0.040 |
Why?
|
Genes, MHC Class II | 2 | 2005 | 433 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1103 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 16045 | 0.040 |
Why?
|
bcl-X Protein | 1 | 2000 | 412 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 1999 | 250 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2008 | 1791 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2022 | 620 | 0.040 |
Why?
|
Odds Ratio | 1 | 2010 | 9669 | 0.040 |
Why?
|
Gene Targeting | 1 | 2001 | 841 | 0.040 |
Why?
|
Nausea | 1 | 2001 | 682 | 0.040 |
Why?
|
Antigens, CD20 | 1 | 2018 | 199 | 0.040 |
Why?
|
Species Specificity | 1 | 2002 | 2415 | 0.040 |
Why?
|
Muramidase | 1 | 1998 | 163 | 0.040 |
Why?
|
Neurology | 1 | 2006 | 786 | 0.040 |
Why?
|
Vital Capacity | 1 | 2000 | 996 | 0.040 |
Why?
|
Pregnancy | 5 | 2024 | 30256 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2633 | 0.040 |
Why?
|
Risk Factors | 5 | 2023 | 74944 | 0.040 |
Why?
|
Veins | 1 | 2021 | 769 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3803 | 0.040 |
Why?
|
Alkylating Agents | 1 | 1997 | 132 | 0.030 |
Why?
|
Immunodominant Epitopes | 1 | 1998 | 244 | 0.030 |
Why?
|
Chemokines | 2 | 2016 | 963 | 0.030 |
Why?
|
Receptors, Interleukin | 2 | 2012 | 243 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1998 | 574 | 0.030 |
Why?
|
Off-Label Use | 1 | 2018 | 185 | 0.030 |
Why?
|
Leg Dermatoses | 1 | 1996 | 20 | 0.030 |
Why?
|
Blood Pressure | 1 | 1992 | 8543 | 0.030 |
Why?
|
Integrin alpha4beta1 | 1 | 2016 | 119 | 0.030 |
Why?
|
Gastroscopy | 1 | 1998 | 213 | 0.030 |
Why?
|
Jordan | 1 | 1996 | 73 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2011 | 14729 | 0.030 |
Why?
|
Clinical Trials as Topic | 4 | 2003 | 8054 | 0.030 |
Why?
|
Immunogenetics | 1 | 2006 | 62 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1998 | 257 | 0.030 |
Why?
|
Iliac Vein | 1 | 1996 | 71 | 0.030 |
Why?
|
Military Personnel | 2 | 2014 | 1261 | 0.030 |
Why?
|
Ischemia | 1 | 2004 | 1900 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 2 | 2006 | 107 | 0.030 |
Why?
|
Lymphocyte Transfusion | 1 | 1997 | 232 | 0.030 |
Why?
|
Facial Dermatoses | 1 | 1996 | 87 | 0.030 |
Why?
|
Neoplasm Metastasis | 3 | 1996 | 4912 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2022 | 1157 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9419 | 0.030 |
Why?
|
Mutation | 3 | 2023 | 30238 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5797 | 0.030 |
Why?
|
Career Choice | 1 | 2022 | 769 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2004 | 1448 | 0.030 |
Why?
|
Schools, Medical | 1 | 2022 | 883 | 0.030 |
Why?
|
Zoonoses | 1 | 1996 | 180 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 777 | 0.030 |
Why?
|
Selectins | 1 | 2015 | 101 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2000 | 737 | 0.030 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2015 | 122 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 9015 | 0.030 |
Why?
|
Agriculture | 1 | 1996 | 186 | 0.030 |
Why?
|
Rats, Inbred BN | 4 | 1997 | 231 | 0.030 |
Why?
|
Drug Synergism | 1 | 1999 | 1760 | 0.030 |
Why?
|
Rodentia | 1 | 1996 | 262 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2010 | 3447 | 0.030 |
Why?
|
Iliac Artery | 1 | 1996 | 344 | 0.030 |
Why?
|
Achievement | 1 | 2016 | 288 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2862 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2003 | 1839 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 693 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8744 | 0.030 |
Why?
|
Janus Kinase 3 | 1 | 2014 | 76 | 0.030 |
Why?
|
Phosphorylation | 1 | 2005 | 8317 | 0.030 |
Why?
|
Phorbol Esters | 1 | 2013 | 109 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 190 | 0.030 |
Why?
|
Interferon-alpha | 1 | 1998 | 910 | 0.030 |
Why?
|
Stomach | 1 | 1998 | 701 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2004 | 2982 | 0.030 |
Why?
|
Problem Solving | 1 | 2016 | 443 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5706 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 2014 | 265 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1998 | 1081 | 0.030 |
Why?
|
Gene Frequency | 2 | 2010 | 3623 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2007 | 6514 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3445 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3610 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3436 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 1996 | 627 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2873 | 0.030 |
Why?
|
Arm | 1 | 1996 | 591 | 0.030 |
Why?
|
Wounds, Gunshot | 3 | 1996 | 586 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1995 | 619 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 463 | 0.030 |
Why?
|
Homeostasis | 1 | 2004 | 3348 | 0.030 |
Why?
|
Skin Diseases | 1 | 2001 | 1085 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 13045 | 0.030 |
Why?
|
Myelitis | 1 | 2013 | 49 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5863 | 0.030 |
Why?
|
Uveitis | 3 | 1994 | 398 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1992 | 170 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2012 | 216 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2010 | 1340 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3390 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7477 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 3 | 2001 | 510 | 0.020 |
Why?
|
Treatment Failure | 3 | 2009 | 2661 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2012 | 107 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2014 | 250 | 0.020 |
Why?
|
Thalamus | 1 | 2018 | 1047 | 0.020 |
Why?
|
Terminology as Topic | 2 | 2010 | 1542 | 0.020 |
Why?
|
Haplorhini | 1 | 1992 | 523 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1993 | 1310 | 0.020 |
Why?
|
Endothelium | 1 | 1994 | 768 | 0.020 |
Why?
|
Nitrosourea Compounds | 1 | 1991 | 32 | 0.020 |
Why?
|
Foreign-Body Migration | 1 | 1993 | 220 | 0.020 |
Why?
|
Predictive Value of Tests | 4 | 2009 | 15454 | 0.020 |
Why?
|
DNA Primers | 1 | 1995 | 2828 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2012 | 514 | 0.020 |
Why?
|
Lipid A | 1 | 1990 | 70 | 0.020 |
Why?
|
Rural Health | 1 | 1992 | 302 | 0.020 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2014 | 279 | 0.020 |
Why?
|
Blast Injuries | 1 | 2014 | 321 | 0.020 |
Why?
|
Incidence | 3 | 2013 | 21538 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.020 |
Why?
|
Vaccination | 2 | 2012 | 3437 | 0.020 |
Why?
|
DNA | 1 | 2004 | 7214 | 0.020 |
Why?
|
Spinal Cord Diseases | 1 | 2013 | 291 | 0.020 |
Why?
|
Carotid Artery Injuries | 1 | 1990 | 96 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1996 | 1443 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2016 | 3096 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1281 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 527 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
Base Sequence | 2 | 2005 | 12421 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5804 | 0.020 |
Why?
|
Embolism | 1 | 1993 | 401 | 0.020 |
Why?
|
Arginine | 1 | 2013 | 932 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 500 | 0.020 |
Why?
|
Glucosylceramides | 1 | 2009 | 27 | 0.020 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2009 | 48 | 0.020 |
Why?
|
Organophosphorus Compounds | 1 | 1991 | 211 | 0.020 |
Why?
|
Supratentorial Neoplasms | 1 | 1991 | 156 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 1998 | 1892 | 0.020 |
Why?
|
Alleles | 2 | 2010 | 6894 | 0.020 |
Why?
|
Optic Nerve Diseases | 1 | 2013 | 342 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 994 | 0.020 |
Why?
|
Laparoscopy | 1 | 2001 | 2041 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2302 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2009 | 361 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 693 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1260 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 559 | 0.020 |
Why?
|
Melatonin | 1 | 2014 | 670 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 1992 | 416 | 0.020 |
Why?
|
Oxygen | 1 | 2000 | 4270 | 0.020 |
Why?
|
Organizations | 1 | 2010 | 172 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1434 | 0.020 |
Why?
|
Hormones | 1 | 1992 | 866 | 0.020 |
Why?
|
Dental Occlusion | 1 | 2008 | 54 | 0.020 |
Why?
|
Cell Cycle | 2 | 2008 | 2932 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3402 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12543 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2008 | 163 | 0.020 |
Why?
|
Graft Survival | 1 | 1999 | 3887 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 667 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1997 | 1805 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2014 | 807 | 0.020 |
Why?
|
Dogs | 1 | 1992 | 3845 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1641 | 0.020 |
Why?
|
Serum | 1 | 2008 | 206 | 0.020 |
Why?
|
Encephalomyelitis | 1 | 2007 | 37 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 286 | 0.020 |
Why?
|
Arthritis, Experimental | 3 | 1995 | 293 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9613 | 0.020 |
Why?
|
Decision Trees | 1 | 2009 | 508 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2784 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 639 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2011 | 2000 | 0.020 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1987 | 82 | 0.020 |
Why?
|
Wallerian Degeneration | 1 | 2006 | 68 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2012 | 1105 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1191 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1906 | 0.020 |
Why?
|
Biopsy | 1 | 1998 | 6793 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2005 | 12800 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2006 | 154 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2006 | 104 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2005 | 92 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2008 | 463 | 0.020 |
Why?
|
Laser Therapy | 1 | 1992 | 1107 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2732 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2008 | 2560 | 0.020 |
Why?
|
Mast Cells | 1 | 2012 | 1406 | 0.010 |
Why?
|
Transplantation, Homologous | 3 | 2000 | 4833 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.010 |
Why?
|
Prostatectomy | 1 | 1992 | 1786 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2012 | 1041 | 0.010 |
Why?
|
Area Under Curve | 1 | 2009 | 1643 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2914 | 0.010 |
Why?
|
Frail Elderly | 1 | 2010 | 781 | 0.010 |
Why?
|
Monitoring, Immunologic | 1 | 2004 | 100 | 0.010 |
Why?
|
Peyer's Patches | 2 | 1995 | 120 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2007 | 914 | 0.010 |
Why?
|
Intestine, Small | 1 | 1990 | 1217 | 0.010 |
Why?
|
Fluorouracil | 2 | 1979 | 1652 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2493 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4858 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26422 | 0.010 |
Why?
|
Endosonography | 1 | 2008 | 626 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2004 | 624 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 979 | 0.010 |
Why?
|
Schools | 1 | 1992 | 1498 | 0.010 |
Why?
|
Forecasting | 1 | 1992 | 2945 | 0.010 |
Why?
|
Hippocampus | 1 | 2006 | 3785 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5884 | 0.010 |
Why?
|
Radiography | 2 | 2010 | 6983 | 0.010 |
Why?
|
Electromyography | 1 | 2008 | 1401 | 0.010 |
Why?
|
Organogenesis | 1 | 2004 | 214 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2566 | 0.010 |
Why?
|
Receptors, Interleukin-18 | 1 | 2002 | 25 | 0.010 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2002 | 18 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2006 | 1609 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 2003 | 863 | 0.010 |
Why?
|
Child, Preschool | 3 | 2009 | 42669 | 0.010 |
Why?
|
Angiography | 1 | 2008 | 1597 | 0.010 |
Why?
|
Arousal | 1 | 2008 | 1180 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3929 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 2012 | 1512 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13014 | 0.010 |
Why?
|
Models, Animal | 1 | 2008 | 2120 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36535 | 0.010 |
Why?
|
Polysomnography | 1 | 2008 | 1871 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2675 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2005 | 8128 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1992 | 2593 | 0.010 |
Why?
|
Stents | 1 | 1992 | 3195 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 1419 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3447 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 697 | 0.010 |
Why?
|
Cattle | 2 | 1996 | 3819 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Cell Death | 1 | 2005 | 1679 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5315 | 0.010 |
Why?
|
Cholesterol | 1 | 2008 | 2914 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5755 | 0.010 |
Why?
|
Antibodies | 1 | 2007 | 2421 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2004 | 2678 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2003 | 1837 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6526 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4503 | 0.010 |
Why?
|
Organ Specificity | 2 | 1994 | 1968 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 1998 | 188 | 0.010 |
Why?
|
Thiazoles | 1 | 2005 | 1542 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2001 | 1703 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3706 | 0.010 |
Why?
|
Vomiting | 1 | 2001 | 655 | 0.010 |
Why?
|
Swine | 1 | 2008 | 5995 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2008 | 1672 | 0.010 |
Why?
|
Protein Conformation | 1 | 2005 | 3956 | 0.010 |
Why?
|
Bone Neoplasms | 2 | 1979 | 2565 | 0.010 |
Why?
|
Apoproteins | 1 | 1996 | 45 | 0.010 |
Why?
|
Tamoxifen | 1 | 2001 | 966 | 0.010 |
Why?
|
Pancreas | 1 | 2003 | 1700 | 0.010 |
Why?
|
Primary Health Care | 1 | 1992 | 4746 | 0.010 |
Why?
|
Cell Lineage | 1 | 2005 | 2575 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1377 | 0.010 |
Why?
|
Estrogens | 2 | 1979 | 1536 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1996 | 2087 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10840 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6283 | 0.010 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1994 | 41 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2004 | 3780 | 0.010 |
Why?
|
Models, Biological | 2 | 2005 | 9495 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1997 | 646 | 0.010 |
Why?
|
HLA-DR2 Antigen | 1 | 1993 | 45 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2809 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2008 | 4530 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3409 | 0.010 |
Why?
|
Sleep | 1 | 2008 | 4819 | 0.010 |
Why?
|
Hypertension | 1 | 1992 | 8616 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 1994 | 445 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 892 | 0.010 |
Why?
|
Heart Injuries | 1 | 1993 | 207 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 1995 | 498 | 0.010 |
Why?
|
Injections | 1 | 1994 | 840 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12795 | 0.010 |
Why?
|
Methotrexate | 1 | 1997 | 1721 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2001 | 1807 | 0.010 |
Why?
|
Indomethacin | 1 | 1990 | 323 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1991 | 642 | 0.010 |
Why?
|
Neck Injuries | 1 | 1990 | 162 | 0.000 |
Why?
|
Prostaglandins | 1 | 1990 | 398 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 2001 | 3488 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1991 | 13676 | 0.000 |
Why?
|
Acute Disease | 1 | 1998 | 7243 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1997 | 6029 | 0.000 |
Why?
|
Surgical Wound Infection | 1 | 1996 | 1546 | 0.000 |
Why?
|
Haplotypes | 1 | 1993 | 2722 | 0.000 |
Why?
|
Calcium | 1 | 2000 | 5792 | 0.000 |
Why?
|
Heart Transplantation | 1 | 2000 | 3301 | 0.000 |
Why?
|
Interleukin-1 | 1 | 1990 | 1252 | 0.000 |
Why?
|
Cause of Death | 1 | 1996 | 3721 | 0.000 |
Why?
|
Epithelium | 1 | 1990 | 1607 | 0.000 |
Why?
|
Vaccines | 1 | 1994 | 842 | 0.000 |
Why?
|
Intestines | 1 | 1994 | 1909 | 0.000 |
Why?
|
Hypersensitivity | 1 | 1994 | 1172 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20760 | 0.000 |
Why?
|
Emergencies | 1 | 1990 | 1221 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1994 | 3044 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1993 | 4249 | 0.000 |
Why?
|
Survival Rate | 1 | 1996 | 12840 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1993 | 3841 | 0.000 |
Why?
|
Research Design | 1 | 1996 | 6211 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1990 | 3703 | 0.000 |
Why?
|
Palliative Care | 2 | 1979 | 3643 | 0.000 |
Why?
|